HLK Biotech Holding Group, Inc.
OTC: AMHD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Anna Petinova
- Employees
- 5
- Headquarters
- Norfolk, United States
- IPO year
- 1999
- Market cap
- $925.0
- Website
- https://www.amelotholdings.com
Loading AMHD…
Loading profile data…Frequently asked questions about AMHD
What does HLK Biotech Holding Group, Inc. (AMHD) do?
HLK Biotech Holding Group, Inc. operates primarily through its various subsidiaries, focusing on the production and distribution of biodiesel. In addition to its energy sector activities, the company also engages in the acquisition of real estate assets. The firm was formerly recognized as Amelot Holdings, Inc., but it officially rebranded to HL...
Where does AMHD trade?
HLK Biotech Holding Group, Inc. (AMHD) trades on the Other OTC.
What sector is AMHD in?
HLK Biotech Holding Group, Inc. (AMHD) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of HLK Biotech Holding Group, Inc.?
Anna Petinova is the chief executive officer of HLK Biotech Holding Group, Inc. (AMHD).
Where is HLK Biotech Holding Group, Inc. headquartered?
HLK Biotech Holding Group, Inc. is headquartered in United States.
Does AMHD pay a dividend?
HLK Biotech Holding Group, Inc. (AMHD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AMHD go public?
HLK Biotech Holding Group, Inc. (AMHD) completed its initial public offering in 1999.